External Source

Ash 2024: Zhuoer Xie Shares New Study Compares Ccus Vs Lower-risk Mds Insights For Personalized Care

2024 1:08
Synopsis
Zhuoer Xie, MD discusses a new study comparing CCUS and lower-risk MDS by looking at their clinical features and outcomes.

You Might Also Like

Post #ASH24 Most Important MDS Studies 56:25
Post #ash24 Most Important Mds Studies
2025
Episode 115: AML Series, Pt. 1 - CHIP, CCUS, ICUS, oh my! 35:20
Episode 115: Aml Series, Pt. 1 - Chip, Ccus, Icus, Oh My!
2024
MDS updates from the ASH 2024 meeting 1:30
Mds Updates From The Ash 2024 Meeting
2024
Pre MDS states CH, CCUS, ICUS – How to manage in the clinic? 20:33
Pre Mds States Ch, Ccus, Icus – How To Manage In The Clini...
2024
ASH Impact Series: David Steensma, MD - Examining Current Research Initiatives in MDS 3:52
Ash Impact Series: David Steensma, Md - Examining Current Re...
2017
Living with MDS Cancer 1:00
Living With Mds Cancer
2022
What Is the Current MDS Treatment Landscape? 9:51
What Is The Current Mds Treatment Landscape?
2024
Real-World Evidence Supports Luspatercept in Lower-Risk MDS 4:12
Real-world Evidence Supports Luspatercept In Lower-risk Mds
2025
MDSR 2024: Clonal Hematopoiesis/Inflammation 1:02:33
Mdsr 2024: Clonal Hematopoiesis/inflammation
2024
David Swoboda Talks MDS Highlights at ASH 2023 4:51
David Swoboda Talks Mds Highlights At Ash 2023
2023
Latest COMMANDS analysis shows luspatercept is transformative in MDS 2:13
Latest Commands Analysis Shows Luspatercept Is Transformativ...
2025
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.